MedTrace Logo

NeuroPath Comparative Validation Study Plan

NCT00393549 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2007-06-06

No results posted yet for this study

Summary

The purpose of the study is to compare the performance of the NeuroPath automated nerve conduction test with the standard of care manual test in the diagnosis of entrapment neuropathies.

Conditions

  • Carpal Tunnel Syndrome (CTS)

Interventions

DEVICE

NeuroPath

Sponsors & Collaborators

  • Excel-Tech Ltd.

    lead INDUSTRY

Principal Investigators

  • Ron Kurtz · Excel-Tech Ltd. (XLTEK)

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00393549 on ClinicalTrials.gov